Search by Drug Name or NDC
NDC 00121-0595-16 Sodium Citrate and Citric Acid 334; 500 mg/5mL; mg/5mL Details
Sodium Citrate and Citric Acid 334; 500 mg/5mL; mg/5mL
Sodium Citrate and Citric Acid is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pharmaceutical Associates, Inc.. The primary component is ANHYDROUS CITRIC ACID; SODIUM CITRATE.
Product Information
NDC | 00121-0595 |
---|---|
Product ID | 0121-0595_efe0dd73-00d4-9223-e053-2a95a90a1bae |
Associated GPIs | 56202020002010 |
GCN Sequence Number | 043912 |
GCN Sequence Number Description | citric acid/sodium citrate SOLUTION 334-500MG ORAL |
HIC3 | R1S |
HIC3 Description | URINARY PH MODIFIERS |
GCN | 51957 |
HICL Sequence Number | 003682 |
HICL Sequence Number Description | CITRIC ACID/SODIUM CITRATE |
Brand/Generic | Generic |
Proprietary Name | Sodium Citrate and Citric Acid |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | SODIUM CITRATE and CITRIC ACID MONOHYDRATE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION |
Route | ORAL |
Active Ingredient Strength | 334; 500 |
Active Ingredient Units | mg/5mL; mg/5mL |
Substance Name | ANHYDROUS CITRIC ACID; SODIUM CITRATE |
Labeler Name | Pharmaceutical Associates, Inc. |
Pharmaceutical Class | Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation F |
DEA Schedule | n/a |
Marketing Category | UNAPPROVED DRUG OTHER |
Application Number | n/a |
Listing Certified Through | 2024-12-31 |
Package
NDC 00121-0595-16 (00121059516)
NDC Package Code | 0121-0595-16 |
---|---|
Billing NDC | 00121059516 |
Package | 473 mL in 1 BOTTLE (0121-0595-16) |
Marketing Start Date | 1969-01-01 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.02569 |
Pricing Unit | ML |
Effective Date | 2024-02-21 |
NDC Description | SOD CITRATE-CITRIC ACID SOLN |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis